Non-small-cell lung cancer

08/27/2013 | Lancet, The

Non-small-cell lung cancer is one of the leading causes of death from cancer worldwide. Therefore, improvements in diagnostics and treatments are urgently needed. In this review, the authors discuss the evolution of lung cancer staging toward more noninvasive, endoscopy-based and image-based methods, and the development of stage-adapted treatment. (Free registration required.)

View Full Article in:

Lancet, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC